Effect of sildenafil on ocular haemodynamics
- PMID: 11767027
- DOI: 10.1038/eye.2001.163
Effect of sildenafil on ocular haemodynamics
Abstract
Purpose: To study the effect of sildenafil, which is an effective agent for the treatment of erectile dysfunction, on ocular haemodynamics.
Methods: In this prospective study we examined the effect of a single oral dose of 50 mg sildenafil (Viagra) in a group of healthy young male volunteers, by using colour Doppler ultrasound imaging to measure haemodynamic variables in the central retinal artery (CRA), short temporal posterior ciliary artery (STPCA) and ophthalmic artery (OA). The following examinations were performed on both eyes immediately before and 1 h after a single oral dose of 50 mg sildenafil: visual acuity, intraocular pressure (IOP), colour vision, anterior segment, fundus appearance, resting heart rate, blood pressure and colour Doppler measurements.
Results: After sildenafil administration, peak systolic velocity, mean velocity and end-diastolic velocity significantly increased in the OA of both eyes. All Dopper indices remained non-significant for the CRA and STPCA of both eyes. Sildenafil did not cause any significant change in IOP, colour vision, visual acuity, systolic blood pressure or diastolic blood pressure. However, heart rate measurements increased significantly after sildenafil administration compared with baseline (p = 0.003).
Conclusion: The increased flow velocity in the ophthalmic artery seems to be due to a vasodilator effect of sildenafil.
Similar articles
-
The effects of sildenafil on ocular blood flow.Acta Ophthalmol Scand. 2005 Jun;83(3):355-9. doi: 10.1111/j.1600-0420.2005.00422.x. Acta Ophthalmol Scand. 2005. PMID: 15948790 Clinical Trial.
-
Effect of sildenafil on ocular hemodynamics in 3 months regular use.Int J Impot Res. 2006 May-Jun;18(3):282-6. doi: 10.1038/sj.ijir.3901416. Int J Impot Res. 2006. PMID: 16292333 Clinical Trial.
-
Diagnostic compatibility of structural and haemodynamic parameters in open-angle glaucoma patients.Acta Ophthalmol. 2008 Aug;86(5):552-7. doi: 10.1111/j.1600-0420.2007.01091.x. Epub 2007 Dec 11. Acta Ophthalmol. 2008. PMID: 18081900 Clinical Trial.
-
Effects of vardenafil on intraocular pressure and orbital hemodynamics.J Ocul Pharmacol Ther. 2007 Jun;23(3):275-9. doi: 10.1089/jop.2006.121. J Ocul Pharmacol Ther. 2007. PMID: 17593011 Clinical Trial.
-
Use of colour Doppler imaging in ocular blood flow research.Acta Ophthalmol. 2011 Dec;89(8):e609-30. doi: 10.1111/j.1755-3768.2011.02178.x. Epub 2011 Oct 11. Acta Ophthalmol. 2011. PMID: 21989301 Review.
Cited by
-
Phosphodiesterase Type 5 Inhibitors and Visual Side Effects: A Narrative Review.J Ophthalmic Vis Res. 2021 Apr 29;16(2):248-259. doi: 10.18502/jovr.v16i2.9088. eCollection 2021 Apr-Jun. J Ophthalmic Vis Res. 2021. PMID: 34055262 Free PMC article. Review.
-
Effects of orally administered moxaverine on ocular blood flow in healthy subjects.Graefes Arch Clin Exp Ophthalmol. 2013 Feb;251(2):515-20. doi: 10.1007/s00417-012-2207-1. Epub 2012 Dec 1. Graefes Arch Clin Exp Ophthalmol. 2013. PMID: 23203292 Clinical Trial.
-
Visual Side Effects Linked to Sildenafil Consumption: An Update.Biomedicines. 2021 Mar 12;9(3):291. doi: 10.3390/biomedicines9030291. Biomedicines. 2021. PMID: 33809319 Free PMC article. Review.
-
Sildenafil dilates ophthalmic artery in type 2 diabetic patients.SAGE Open Med. 2013 Aug 20;1:2050312113495195. doi: 10.1177/2050312113495195. eCollection 2013. SAGE Open Med. 2013. PMID: 26770675 Free PMC article.
-
Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension.BMJ. 2012 Feb 21;344:e554. doi: 10.1136/bmj.e554. BMJ. 2012. PMID: 22354598 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical